Published: 4 March 2021
Publications
Recent approvals: new active ingredients or new indications
Published: 4 March 2021
Prescriber Update 42(1): 11
March 2021
For the period 16 October 2020 to 15 January 2021.
Recent approvals of medicines with new active ingredients
| Trade name (active ingredient) | Dose form and strength(s) | Therapeutic area |
|---|---|---|
| Constella (linaclotide) | Capsule 72 mcg 145 mcg 290 mcg |
Chronic idiopathic constipation Irritable bowel syndrome |
| Parizem (paricalcitol) | Liquid filled capsule 1 mcg 2 mcg |
Secondary hyperparathyroidism |
| Rinvoq (upadacitinib hemihydrate | Modified release tablet 15 mg |
Rheumatoid arthritis |
Approved medicines with new indications
| Trade Name (active ingredient) | Dose form and strength(s) | New therapeutic area(s) |
|---|---|---|
| Dexmethsone (dexamethasone) | Tablet 0.5 mg 4 mg |
Coronavirus (COVID-19) infection |
See the Medsafe website for:
